[go: up one dir, main page]

KR900700098A - Plaboxate and its derivatives for the treatment and diagnosis of erectile dysfunction - Google Patents

Plaboxate and its derivatives for the treatment and diagnosis of erectile dysfunction

Info

Publication number
KR900700098A
KR900700098A KR1019890702417A KR890702417A KR900700098A KR 900700098 A KR900700098 A KR 900700098A KR 1019890702417 A KR1019890702417 A KR 1019890702417A KR 890702417 A KR890702417 A KR 890702417A KR 900700098 A KR900700098 A KR 900700098A
Authority
KR
South Korea
Prior art keywords
erectile dysfunction
diagnosis
treatment
methylflavone
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019890702417A
Other languages
Korean (ko)
Inventor
랄프 루프만
Original Assignee
람베르토 안드레오티
레코르다티 소시에타 아노니마 케미칼 앤드 파마슈티칼 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 람베르토 안드레오티, 레코르다티 소시에타 아노니마 케미칼 앤드 파마슈티칼 캄파니 filed Critical 람베르토 안드레오티
Publication of KR900700098A publication Critical patent/KR900700098A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

내용 없음No content

Description

발기부전의 치료겸 진단용 플라복세이트 및 그 유도체Plaboxate and its derivatives for the treatment and diagnosis of erectile dysfunction

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (5)

3-메틸플라본-8-카르복실산 또는 그 유도체 또는 하기 일반식(Ⅰ)의 화합물 또는 제약상 허용되는 그 염의 발기부전 치료겸 진단용 의약의 제조 용도.Use of the manufacture of a medicament for treating and diagnosing erectile dysfunction of 3-methylflavone-8-carboxylic acid or a derivative thereof or a compound of formula (I) or a pharmaceutically acceptable salt thereof. 식 중, A는 직쇄 또는 분지쇄 C1-C6알킬기이고, Z은 디메틸아미노, 디에틸아미노, 디-n-프로필아미노, 디이소프로필아미노, 피페리디노 또는 모르폴리노 잔기이다.Wherein A is a straight or branched C 1 -C 6 alkyl group and Z is a dimethylamino, diethylamino, di-n-propylamino, diisopropylamino, piperidino or morpholino residue. 3-메틸플라본-8-카르복실산 또는 제약상 허용되는 그 염의 발기부전 치료겸 진단용 의약의 제조용도.Use for the manufacture of a medicament for the treatment and diagnosis of erectile dysfunction of 3-methylflavone-8-carboxylic acid or a pharmaceutically acceptable salt thereof. 2-피페리디노-에틸 3-메틸플라본-8-카르복실레이트 또는 제약상 허용되는 그 염의 발기부전 치료겸 진단용 의약의 제조 용도.Use of a 2-piperidino-ethyl 3-methylflavone-8-carboxylate or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment and diagnosis of erectile dysfunction. 적합한 담체와 함께 3-메틸플라본-8-카르복실산 또는 그 염 또는 하기 일반식(Ⅰ)의 화합물 또는 제약상 허용되는 그 염으로 이루어짐이 특징인 발기부전 치료용 제약 조성물.A pharmaceutical composition for treating erectile dysfunction characterized by consisting of 3-methylflavone-8-carboxylic acid or a salt thereof or a compound of formula (I) or a pharmaceutically acceptable salt thereof with a suitable carrier. 식 중, A는 직쇄 또는 분지쇄 C1-C6알킬기이고, Z은 디메틸아미노, 디에틸아미노, 디-n-프로필아미노, 디이소프로필아미노, 피페리디노 또는 모르폴리노 잔기이다.Wherein A is a straight or branched C 1 -C 6 alkyl group and Z is a dimethylamino, diethylamino, di-n-propylamino, diisopropylamino, piperidino or morpholino residue. 제4항에 있어서, 경구, 국소 또는 비경구 투여에 적합한 제약 조성물.A pharmaceutical composition according to claim 4 suitable for oral, topical or parenteral administration. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019890702417A 1988-04-22 1989-04-19 Plaboxate and its derivatives for the treatment and diagnosis of erectile dysfunction Withdrawn KR900700098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT20299A/88 1988-04-22
IT20299/88A IT1217190B (en) 1988-04-22 1988-04-22 USEFUL COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF HURRY DYSFUNCTIONS
PCT/EP1989/000417 WO1989010123A1 (en) 1988-04-22 1989-04-19 Flevoxate and derivatives for erectile dysfunctions

Publications (1)

Publication Number Publication Date
KR900700098A true KR900700098A (en) 1990-08-11

Family

ID=11165532

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890702417A Withdrawn KR900700098A (en) 1988-04-22 1989-04-19 Plaboxate and its derivatives for the treatment and diagnosis of erectile dysfunction

Country Status (8)

Country Link
EP (1) EP0374210A1 (en)
JP (1) JPH02504146A (en)
KR (1) KR900700098A (en)
AU (1) AU3438289A (en)
HU (1) HU202754B (en)
IT (1) IT1217190B (en)
WO (1) WO1989010123A1 (en)
ZA (1) ZA892911B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
US6143746A (en) * 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
GB9514465D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
GB9423910D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
GB9423911D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
GB9514464D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
GB9514473D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
AP9801365A0 (en) * 1996-05-10 1998-12-31 Icos Corp Carboline derivatives.
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
WO2003042216A1 (en) 2001-11-09 2003-05-22 Schering Corporation Polycyclic guanine derivative phosphodiesterase v inhibitors
EP2470174A1 (en) * 2009-08-27 2012-07-04 Merck Patent GmbH Use of faa and its derivatives in cosmetics and dermatology

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0266968A3 (en) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent

Also Published As

Publication number Publication date
IT1217190B (en) 1990-03-14
AU3438289A (en) 1989-11-24
ZA892911B (en) 1989-12-27
HU892651D0 (en) 1990-11-28
IT8820299A0 (en) 1988-04-22
JPH02504146A (en) 1990-11-29
EP0374210A1 (en) 1990-06-27
HUT53804A (en) 1990-12-28
WO1989010123A1 (en) 1989-11-02
HU202754B (en) 1991-04-29

Similar Documents

Publication Publication Date Title
KR940007022A (en) Piperidine derivatives, their use in the preparation and treatment thereof
KR880001591A (en) Tetrahydro Naphthalene and Phosphorus Derivatives
KR880002834A (en) α-alkyl-4-amino-3-quinolinmethanol and 1- (4-aralkylamino-3-quinolinyl) alkanones, methods for their preparation and use as medicaments
KR890016966A (en) New antiviral agents
KR880011125A (en) Heterocyclic Compounds, Methods for Making and Uses thereof
KR880006193A (en) Piperidine Compounds and Their Preparation and Uses
KR900700098A (en) Plaboxate and its derivatives for the treatment and diagnosis of erectile dysfunction
KR930703303A (en) 1,4-benzothiazepine derivative
KR880007514A (en) Chinoline compounds
KR890007738A (en) Ergoline derivative for the treatment of Parkinson's disease
KR900016098A (en) Derivatives of Caffeic Acid and Pharmaceutical Compositions Containing the Same
KR890005088A (en) 4-aminopyridine derivatives and acid addition salts thereof
DE3869075D1 (en) 2-PIPERAZINYL-2-OXO-AETHYLENE-SUBSTITUTED FLAVONOID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
KR890003752A (en) Use of 2-pyrimidinyl-piperadine derivatives
KR920004387A (en) 4-substituted dihydropyrido [4,3-d] pyrimidines as topical anti-inflammatory agents for the treatment of analgesics and skin diseases
KR880007462A (en) Propiophenone Derivatives for the Treatment of Frequency
KR920007995A (en) Benzamide derivatives
KR880000432A (en) 4 (3H) -oxo-5,6,7,8-tetrahydropyrido-2,3-d pyrimidine derivative
KR890006639A (en) Benzothiazine dioxide derivatives
KR890009901A (en) 3-hydroxy-2- (4-methoxyphenyl) -5- (2-methylaminoethyl) -2,3-dihydro-5H-1,5-benzothiazepin-4-one derivative, its preparation and The use to the treatment
KR890003755A (en) 7- (2-Methyl-4-aminopyrrolidinyl) naphthyridine and quinoline compounds
KR920005986A (en) Pharmaceutical composition for inhibiting platelet aggregation
KR910015301A (en) Treatment of Sleep Apnea
KR900701273A (en) Anti-Ecstatic Ergoline Derivatives
KR870006043A (en) Pyrazine derivatives manufacturing method and pharmaceutical composition

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19891221

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid